Phio Pharmaceuticals News - PHIO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.22 -9.48% 2.10 2.0201 2.39 2.39 2.32 20:00:00
more quote information »

Recent News

Date Time Source Heading
3/26/202017:27EDGARCurrent Report Filing (8-k)
3/26/202017:26EDGARAnnual Report (10-k)
3/12/202016:16EDGARCurrent Report Filing (8-k)
2/24/202017:28EDGARSmall Company Offering and Sale of Securities Without..
2/14/202014:52EDGARStatement of Ownership (sc 13g)
2/13/202017:27EDGARCurrent Report Filing (8-k)
2/13/202017:25EDGARStatement of Ownership (sc 13g)
2/12/202017:22EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
2/12/202006:01EDGARNotice of Effectiveness (effect)
2/11/202013:04EDGARStatement of Ownership (sc 13g)
2/10/202015:19EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202008:00EDGARCurrent Report Filing (8-k)
2/07/202014:30EDGARSecurities Registration Statement (s-1/a)
2/06/202017:06EDGARCurrent Report Filing (8-k)
2/06/202006:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/31/202017:29EDGARSecurities Registration Statement (s-1/a)
1/22/202011:30EDGARAmended Statement of Ownership (sc 13g/a)
1/10/202017:22EDGARCurrent Report Filing (8-k)
12/18/201907:30EDGARCurrent Report Filing (8-k)
12/13/201916:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/13/201908:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/06/201917:16EDGARAmended Current Report Filing (8-k/a)
11/22/201917:23EDGARProxy Statement (definitive) (def 14a)
11/20/201906:02EDGARCurrent Report Filing (8-k)
11/18/201917:24EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/18/201907:29EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/13/201917:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/12/201917:21EDGARCurrent Report Filing (8-k)
11/12/201907:45EDGARCurrent Report Filing (8-k)
11/12/201907:31EDGARQuarterly Report (10-q)
11/08/201917:20EDGARProxy Statement - Notice of Shareholders Meeting..
11/08/201917:12EDGARAmended Current Report Filing (8-k/a)
10/25/201917:26EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/25/201917:26EDGARCurrent Report Filing (8-k)
10/15/201917:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/11/201916:24EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/02/201918:04EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/02/201906:00EDGARNotice of Effectiveness (effect)
10/01/201918:41EDGARSecurities Registration Statement (s-1)
9/25/201917:07EDGARSecurities Registration Statement (s-1/a)
8/30/201917:29EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/30/201917:28EDGARSecurities Registration Statement (s-1)
8/30/201917:27EDGARProxy Statement (definitive) (def 14a)
8/15/201907:05PRNUSPhio Pharmaceuticals and Helmholtz Zentrum M√ľnchen to..
8/12/201917:11EDGARCurrent Report Filing (8-k)
8/12/201917:10PRNUSPhio Pharmaceuticals Reports Second Quarter 2019 Financial..
8/12/201917:01EDGARQuarterly Report (10-q)
8/12/201916:51EDGARProxy Statement - Notice of Shareholders Meeting..
8/09/201917:21EDGARCurrent Report Filing (8-k)
5/20/201907:05PRNUSPhio Pharmaceuticals to Present at Sachs Associates 5th..
See more news about this stock »
Your Recent History
NASDAQ
PHIO
Phio Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200328 14:00:40